Genesis Study

Name: Genesis Study
Availability: InStock
Author: Eclat SRL

Eclat SRL

Everyone

100+

Downloads

Everyone

Learn more

About this app

A 12-month randomised, double-blind, controlled, international multicentre trial comparing changes in cigarette consumption after switching to high or low nicotine strength e-cigarettes in smokers with Schizophrenia spectrum disorders. This will be a multicenter, 12-months prospective trial, utilizing a randomized, double-blind, 2-arm parallel, switching design to compare effectiveness, tolerability, acceptability, and pattern of use between high (JUUL 5% nicotine) and low nicotine strength devices (JUUL 1.5% nicotine) in adult smokers with schizophrenia spectrum disorders. The study will take place at 5 sites: 1 in the UK (London) and possibly 4 in Italy.

App aims to monitor and support smokers with Schizophrenia spectrum disorders.

Updated on

Aug 14, 2026

Data safety

Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.

No data shared with third parties
Learn more about how developers declare sharing
This app may collect these data types
App info and performance
Data is encrypted in transit
You can request that data be deleted